Related references
Note: Only part of the references are listed.Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer
Alberto L'Abbate et al.
NUCLEIC ACIDS RESEARCH (2014)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen et al.
CELL REPORTS (2014)
p53-dependent Induction of PVT1 and miR-1204
Anthony M. Barsotti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells
Lei You et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Meng Li et al.
NATURE GENETICS (2011)
Genome profiling of ERBB2-amplified breast cancers
Fabrice Sircoulomb et al.
BMC CANCER (2010)
Modeling human osteosarcoma in the mouse: From bedside to bench
Katherine A. Janeway et al.
BONE (2010)
Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas
Joshua D. Schiffman et al.
CANCER RESEARCH (2010)
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
Victor Enciso-Mora et al.
NATURE GENETICS (2010)
High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors
Peter M. Haverty et al.
BMC MEDICAL GENOMICS (2009)
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), Amplified on Chromosome 9, Collaborate with p53 Deficiency in Mouse Osteosarcoma Progression
Ou Ma et al.
CANCER RESEARCH (2009)
20 years studying p53 functions in genetically engineered mice
Lawrence A. Donehower et al.
NATURE REVIEWS CANCER (2009)
Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization
Anitha Kamath et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
Carl R. Walkley et al.
GENES & DEVELOPMENT (2008)
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma
Xin-Yan Lu et al.
MOLECULAR CANCER RESEARCH (2008)
The identification of microRNAs in a genomically unstable region of human chromosome 8q24
Konrad Huppi et al.
MOLECULAR CANCER RESEARCH (2008)
Pvt1-encoded microRNAs in oncogenesis
Gabriele B. Beck-Engeser et al.
RETROVIROLOGY (2008)
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer
Yinghui Guan et al.
CLINICAL CANCER RESEARCH (2007)
Bcl-2 and Bcl-XL regulate proinf lammatory caspase-1 activation by interaction with NALP1
Jean-Marie Bruey et al.
CELL (2007)
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma
TK Man et al.
BMC CANCER (2004)
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma
CC Lau et al.
GENES CHROMOSOMES & CANCER (2004)
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability
M Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
High metastatic potential in mice inheriting a targeted p53 missense mutation
G Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
